Entering text into the input field will update the search result below

My International Portfolio: Expanding The Dividend And Risk-On

Dec. 05, 2021 12:43 AM ETABBV, AVGO, BABA, BHP, BTI, DNSKF, FVRR, GD, KO, LMT, MA, MTCH, NKE, NVO, PINS, RBLX, SHEL, RY, T, TSN, TXN, V, RY:CA15 Comments
C Jessen profile picture
C Jessen
1.95K Followers

Summary

  • Your main street neighbour investor in his early 30s sharing his investment journey pursuing a dividend growth strategy with a twist given my age and risk profile.
  • Expanding my forward dividends significantly through expansion of existing holdings as well as new additions.
  • The portfolio is just shy of $170,000 at this point striving to add as much as I can to ensure time in the market as opposed to timing the market.
  • Still learning as an investor, I elaborate on that here.

Playful mature couple piggybacking in winter day.

BraunS/E+ via Getty Images

Disclosure

Within this article, the company Novo Nordisk A/S (NVO) will be mentioned. For the reader, I'd like to disclose that I'm an employee of the company. The nature of my position is an office job that does

This article was written by

C Jessen profile picture
1.95K Followers
Early 30s 'buy and hold' investor trying to achieve financial freedom to the greatest extent possible. Main focus within dividend growth investing & value. I've been investing for 10+ years and worked across several industries including finance, logistics, oil and pharma. Holding a Graduate Diploma within Accounting and MSc within Business Administration & Supply Chain Management.I cover companies matching my focus as well as portfolio strategy

Analyst’s Disclosure: I/we have a beneficial long position in the shares of DDAIF, CSCO, NVO, BAYZF, NKE, V, NSRGY, MHGVY, AAPL, ABBV, TXN, WBA, ENB, RHHBY, GD, RDS.B, AVGO, MCD, RY, UGI, LYB, LMT, MO, BHP, BABA, BTI, SHOP, TTD, PINS, FVRR, ETSY, TSN, RBLX, MTCH, SEMR, T either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Within this article, the company Novo Nordisk A/S (NVO) will be mentioned. For the reader, I'd like to disclose that I'm an employee of the company. The nature of my position is an office job that does not concern sales.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.